StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Aspira Women's Health's price to book ratio was 25.7× on Jul 31, 2023, against 4.1× a year earlier. Over the last 5 years it ranged from 2.3× to 82.0×, with a median of 7.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jul 31, 202325.7×+22.0
2022Dec 30, 20223.7×−1.5
2021Dec 31, 20215.2×−42.8
2020Dec 31, 202048.0×+41.3
2019Dec 31, 20196.7×+4.3
2018Dec 31, 20182.3×−17.2
2017Dec 29, 201719.6×+11.7
2016Dec 30, 20167.9×+3.7
2015Dec 31, 20154.2×−1.5
2014Dec 31, 20145.7×+0.3
2013Dec 31, 20135.4×+1.8
2012Dec 31, 20123.6×+2.3
2011Dec 30, 20111.3×–

More Aspira Women's Health figures

See a number that looks wrong?